5R. R. Wauer,G. Schmalisch,B. B?hme,J. Arand,D. Lehmann. Randomized double blind trial of Ambroxol for the treatment of respiratory distress syndrome[J] 1992,European Journal of Pediatrics(5):357～363
3[1]Couser RJ,Ferrara BT,Ebert J,et al.Effects of exogenous surfactant therapy on dynamic compliance during mechanical breathing in preterm infants with hyaline membrane disease.J Pediatr, 1990,116(1):119
4[2]Bhat R,Dedzic K,Bhutani VK,et al. Effect of single dose surfactant on pulmonary function. Crit Care Med,1990,18(6):590
5[3]Sandberg KL,Lindstrom DP,Sjoqvist BA,et al.Surfactant replacement therapy improves ventilation in infants with respiratory distress syndrome. Pediatr Pulmonol, 1997,24(5):337
6[4]Morley CJ,Greenough A. Respiratory compliance in premture babies treated with artificial surfactant (ALEC). Arch Dis Child,1991,66(4):467
7[5]Bjorklund LJ, Vilstrup CT,Larsson A,et al. Changes in lung volume and static expiratory pressure-volume diagram after surfactant rescue treatment of neonates with established respiratory distress syndrome. Am J Respir Crit Care Med, 1996 Oct, 154 (4Pt1):918
8[6]Gommers D,Vilstrup C,Bos JAH,et al. Exogenous surfactant therapy increases static lung compliance, and cannot be assessed by measurements of dynamic compliance alone. Crit Care Med, 1993,21(4): 567
9[7]Kelly E, Bryan H, Poesmayer F,et al.Compliance of the respiratory system in newborn infants pre-and postsurfactant replacement therapy. Pediatr Pulmonol, 1993,15(4):225
